Trevi Therapeutics, Inc. (TRVI) Balance Sheet
As of 2026-06-30 (10-Q), Trevi Therapeutics, Inc. (TRVI) reported total assets of $330.5M, total liabilities of $9.0M and shareholders' equity of $321.5M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $54.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TRVITrevi Therapeutics, Inc.Follow TRVI — free
—
Price chart with a free account
- Market cap
- 1.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 57.3 | 45.0 | 36.8 | 12.6 | 32.4 | 34.1 | 18.9 | 54.3 | |
| Short-term investments | — | — | — | 107.9 | 50.6 | 73.5 | 169.3 | 264.6 | |
| Current assets | 59.6 | 46.3 | 38.0 | 122.6 | 87.5 | 109.4 | 191.7 | 325.7 | |
| Total assets | 60.0 | 47.1 | 38.5 | 123.0 | 89.4 | 110.9 | 193.4 | 330.5 | |
| Current liabilities | 5.2 | 5.6 | 12.7 | 13.4 | 5.8 | 10.5 | 9.7 | 8.7 | |
| Total liabilities | — | 19.8 | 21.4 | 15.6 | 6.9 | 11.3 | 10.2 | 9.0 | |
| Shareholders' equity | 54.5 | 27.3 | 17.1 | 107.5 | 82.5 | 99.6 | 183.2 | 321.5 |
USD millions · SEC XBRL
Trevi Therapeutics, Inc. — questions
- How much cash does Trevi Therapeutics, Inc. have?
- $54.3M in cash and cash equivalents as of 2026-06-30.
- What are Trevi Therapeutics, Inc.'s total assets?
- $330.5M as of 2026-06-30.
- What is Trevi Therapeutics, Inc.'s shareholders' equity?
- $321.5M as of 2026-06-30.
Every figure on this page comes from Trevi Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.